Catheter Ablation is Superior to Antiarrhythmic Drugs as First-Line Treatment for Atrial Fibrillation: a Systematic Review and Meta-Analysis.

MLA

Cardoso, Rhanderson, et al. “Catheter Ablation Is Superior to Antiarrhythmic Drugs as First-Line Treatment for Atrial Fibrillation: A Systematic Review and Meta-Analysis.” Arquivos Brasileiros de Cardiologia, vol. 119, no. 1, July 2022, pp. 87–94. EBSCOhost, https://doi.org/10.36660/abc.20210477.

APA

Cardoso, R., Justino, G. B., Graffunder, F. P., Benevides, L., Knijnik, L., Sanchez, L. M. F., & d’Avila, A. (2022). Catheter Ablation is Superior to Antiarrhythmic Drugs as First-Line Treatment for Atrial Fibrillation: a Systematic Review and Meta-Analysis. Arquivos Brasileiros de Cardiologia, 119(1), 87–94. https://doi.org/10.36660/abc.20210477

Chicago

Cardoso, Rhanderson, Gustavo B Justino, Fabrissio P Graffunder, Leticia Benevides, Leonardo Knijnik, Luana M F Sanchez, and Andre d’Avila. 2022. “Catheter Ablation Is Superior to Antiarrhythmic Drugs as First-Line Treatment for Atrial Fibrillation: A Systematic Review and Meta-Analysis.” Arquivos Brasileiros de Cardiologia 119 (1): 87–94. doi:10.36660/abc.20210477.